Key result
Electroconvulsive therapy triggers Takotsubo cardiomyopathy despite beta-blocker prophylaxis in a rare case report.
Why the study?
Takotsubo cardiomyopathy is a rare complication of electroconvulsive therapy, and improved clinical understanding could enhance early recognition of patients at risk.
Does electroconvulsive therapy trigger Takotsubo cardiomyopathy in a patient receiving adjuvant beta-blocker therapy?
Case Report (n=1)
Does electroconvulsive therapy trigger Takotsubo cardiomyopathy in a patient receiving adjuvant beta-blocker therapy?
Adjuvant beta-blocker therapy with propranolol did not prevent the occurrence of Takotsubo cardiomyopathy following electroconvulsive therapy.
Answers are grounded in this paper and cite their sources.
Beta-blockers may not prevent Takotsubo cardiomyopathy after ECT; leaves open risk stratification and monitoring needs in clozapine-treated patients.
Takotsubo cardiomyopathy (TC) is a rare complication of electroconvulsive therapy (ECT), an effective and safe treatment for severe cases of depression and psychosis. There are reports on 16 patients who developed TC after ECT, and these were predominantly female patients treated with antidepressants for depressive disorder. We describe a case of a 40-year-old male patient, with a history of schizophrenia and heavy caffeine and nicotine use, treated for acute psychotic episode with haloperidol and clozapine. Propranolol was administered because of clozapine-induced tachycardia. After 8 weeks without therapeutic response, the patient was referred for standard ECT procedure, which included premedication and bifrontotemporal stimulation. Two hours later, the patient experienced gastric pain and had increased troponin and natriuretic peptide levels and ST-elevation. After inotrope and anticoagulant treatment and replacement of antipsychotics, the patient remained stable. Contrary to common opinion, previous adrenergic blockade in this patient did not prevent TC occurrence. TC pathophysiology remains unclear although it has been related to the burst of norepinephrine neurons. Psychosis has also been associated with catecholamine dysfunction, and excessive psychological stress with long-term norepinephrine dysfunction. Animal models have shown that ECT, clozapine, and nicotine and caffeine use could considerably increase catecholamine levels. Clinical understanding of rare cardiac ECT complications could improve early recognition of patients at risk for TC and ensure safe ECT protocols.
No takes yet. Share an insight, caveat, or question.
Medved et al. (2018) conducted a case report in Psychosis and treatment-resistant schizophrenia (n=1). Electroconvulsive therapy (ECT) was evaluated on Development of Takotsubo cardiomyopathy. A 40-year-old male psychotic patient developed Takotsubo cardiomyopathy after his first electroconvulsive therapy session despite prophylactic beta-blocker treatment, highlighting a rare but severe cardiac complication potentially exacerbated by concomitant clozapine, nicotine, and caffeine use.
Synapse has enriched 10 related papers. Consider them for comparative context: